More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage ...
The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback